Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slava Stamova

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecular Immunology|October 22, 2011
Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker moduleSlava Stamova, Marc Cartellieri, Anja Feldmann, et al.
Oncoimmunology|February 6, 2014
TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunityMarc Cartellieri, Claudia Arndt, Anja Feldmann, et al.
Frontiers in Immunology|August 30, 2024
IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cellsFranziska Christine Sanna, Iva Benešová, Philip Pervan, et al.
Oncoimmunology|November 20, 2019
Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancerSeyer Safi, Yoshikane Yamauchi, Slava Stamova, et al.
Plos One|April 5, 2014
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cellsMarc Cartellieri, Stefanie Koristka, Claudia Arndt, et al.
Plos One|February 2, 2011
A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs)Claudia C Bippes, Anja Feldmann, Slava Stamova, et al.
The Journal of Clinical Investigation|January 7, 2015
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
The Journal of Clinical Investigation|March 3, 2015
Corrigendum. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant GliomaSteffen Dettling, Slava Stamova, Rolf Warta, et al.
Acta Neuropathologica|March 24, 2017
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimensCarmen Rapp, Rolf Warta, Slava Stamova, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular Immunology|October 22, 2011
Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker moduleSlava Stamova, Marc Cartellieri, Anja Feldmann, et al.
Oncoimmunology|February 6, 2014
TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunityMarc Cartellieri, Claudia Arndt, Anja Feldmann, et al.
Frontiers in Immunology|August 30, 2024
IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cellsFranziska Christine Sanna, Iva Benešová, Philip Pervan, et al.
Oncoimmunology|November 20, 2019
Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancerSeyer Safi, Yoshikane Yamauchi, Slava Stamova, et al.
Plos One|April 5, 2014
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cellsMarc Cartellieri, Stefanie Koristka, Claudia Arndt, et al.
Plos One|February 2, 2011
A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs)Claudia C Bippes, Anja Feldmann, Slava Stamova, et al.
The Journal of Clinical Investigation|January 7, 2015
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
The Journal of Clinical Investigation|March 3, 2015
Corrigendum. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosisChristoph Reissfelder, Slava Stamova, Christina Gossmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant GliomaSteffen Dettling, Slava Stamova, Rolf Warta, et al.
Acta Neuropathologica|March 24, 2017
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimensCarmen Rapp, Rolf Warta, Slava Stamova, et al.
Pageof 3